Post-myocardial infarction fibrosis: Pathophysiology, examination, and intervention
X Yin, X Yin, X Pan, J Zhang, X Fan, J Li… - Frontiers in …, 2023 - frontiersin.org
Cardiac fibrosis plays an indispensable role in cardiac tissue homeostasis and repair after
myocardial infarction (MI). The cardiac fibroblast-to-myofibroblast differentiation and …
myocardial infarction (MI). The cardiac fibroblast-to-myofibroblast differentiation and …
Circulating sphingolipids in heart failure
Lack of significant advancements in early detection and treatment of heart failure have
precipitated the need for discovery of novel biomarkers and therapeutic targets. Over the …
precipitated the need for discovery of novel biomarkers and therapeutic targets. Over the …
Identification and quantification of human relaxin proteins by immunoaffinity-mass spectrometry
Y Rais, AP Drabovich - Journal of Proteome Research, 2024 - ACS Publications
The human relaxins belong to the Insulin/IGF/Relaxin superfamily of peptide hormones, and
their physiological function is primarily associated with reproduction. In this study, we …
their physiological function is primarily associated with reproduction. In this study, we …
Volenrelaxin (LY3540378) increases Renal Plasma Flow: A Randomized Phase 1 Trial
LS Tham, HJL Heerspink, X Wang… - Nephrology Dialysis …, 2024 - academic.oup.com
Abstract Background and Hypothesis Volenrelaxin, is a half-life-extended recombinant
human relaxin protein developed for improving kidney perfusion and cardiorenal function …
human relaxin protein developed for improving kidney perfusion and cardiorenal function …
[PDF][PDF] 基于数据挖掘与网络药理学的慢性心力衰竭中医证型, 用药规律及相关药理分析
魏佳明， 刘承鑫， 李雅， 郭志华 - 天然产物研究与开发, 2023 - trcw.ac.cn
1 湖南中医药大学第一中医临床学院; 2 湖南中医药大学药学院; 3 湖南中医药大学中医学院; 4
湖南中医药大学慢病中医智能诊断与治未病湖南省普通高等学校重点实验室, 长沙410208 摘要 …
湖南中医药大学慢病中医智能诊断与治未病湖南省普通高等学校重点实验室, 长沙410208 摘要 …
[PDF][PDF] Релаксин как биологический маркёр и терапевтическая мишень при сердечной недостаточности
АМ Алиева, ЕВ Резник, ИЕ Байкова… - Российский …, 2023 - researchgate.net
АННОТАЦИЯ Важная задача современной кардиологии—поиск и изучение новых
сердечно-сосудистых биологических маркёров для ранней диагностики заболеваний …
сердечно-сосудистых биологических маркёров для ранней диагностики заболеваний …
[PDF][PDF] Die Rolle epikardialer stromaler Zellen in der Heilungsphase nach Myokardinfarkt
R Zalfen - 2024 - docserv.uni-duesseldorf.de
Nach einem Myokardinfarkt wird das Epikard aktiviert und es bildet sich eine Multizellschicht
aus proliferierenden, epikardialen stromalen Zellen (EpiSCs), in denen Teile des …
aus proliferierenden, epikardialen stromalen Zellen (EpiSCs), in denen Teile des …
[PDF][PDF] Die Hemmung der Sphingosin-1-Phosphat (S1P)-Lyase verbessert die post-ischämische kardiale Heilung via S1P-Rezeptor 1
S Ahlbrecht - 2023 - docserv.uni-duesseldorf.de
Noch immer stellen kardiovaskuläre Erkrankungen, zu denen der akute Myokardinfarkt
(AMI) zählt, die häufigste Todesursache weltweit dar. Die chronische Herzinsuffizienz als …
(AMI) zählt, die häufigste Todesursache weltweit dar. Die chronische Herzinsuffizienz als …
Relaxin as a biological marker and therapeutic target in heart failure
AM Alieva, EV Reznik, IE Baykova, NV Teplova… - Russian …, 2023 - medjrf.com
An important task of modern cardiology is the search and study of new cardiovascular
biological markers that can help in the early diagnosis of heart diseases, serve as a tool to …
biological markers that can help in the early diagnosis of heart diseases, serve as a tool to …
[引用][C] Βιοδείκτες καρδιαγγειακών νοσημάτων: Παθοβιοχημεία, αρχή μεθόδων προσδιορισμού, τρέχουσες και νέες θεραπείες
Χ ΚΟΥΝΙΑ